American International Group’s Margin Rebounded, but EPS Fell 10%

AIG reported Q2 FY2026 revenue of $7.085B, almost unchanged from $7.090B in Q2 FY2025. With no company guidance or consensus estimate supplied, the prior-year quarter is the required reference. On that basis, revenue missed by $5M, or roughly 0.1%. The top line therefore offered little evidence of year-over-year expansion, even though it improved 6.5% from $6.65B in Q1 FY2026.

Earnings were weaker against the prior year. EPS declined to $1.78 from $1.98, a 10.1% reduction. Pre-tax margin, the relevant operating-margin measure for this financial company, fell to 17.8% from 21.8%. That 4.0-percentage-point contraction is the quarter’s most important negative change because nearly flat revenue translated into a more pronounced decline in per-share earnings.

The sequential comparison was more constructive. EPS rose from $1.41 in Q1 FY2026 to $1.78, while pre-tax margin recovered from 14.8% to 17.8%. Revenue also increased from $6.65B to $7.085B. The print therefore describes a business recovering from the immediately preceding quarter but not matching the stronger profitability achieved one year earlier.

The quarterly table reports $1.72B of free cash flow, up from $1.39B a year earlier and $0.15B in Q1. That figure should not be treated like industrial free cash flow. Insurer cash flows reflect premiums, claims, investment activity and regulatory capital movements, while reported capital expenditure captures only a small part of the economic reinvestment requirement. Gross margin is similarly not meaningful for AIG. Those measures are marked not meaningful rather than counted as earnings beats.

The quarter weakens any argument that AIG has already established a structurally higher profitability level. The 17.8% pre-tax margin was healthy relative to Q1 and above the 14.5% reported for FY2025, but it remained below the unusually strong 21.8% recorded in Q2 FY2025. A single sequential rebound is not enough to establish a new margin baseline when the year-over-year comparison moved in the opposite direction.

Longer-term figures show why the distinction matters. AIG’s annual pre-tax margin improved from 10.3% in FY2023 to 14.2% in FY2024 and 14.5% in FY2025. Q2 FY2026 was above that recent annual level, suggesting that the business has not lost all of its prior profitability progress. Yet Q1 and Q2 together were mixed rather than uniformly stronger: the first-quarter margin was 14.8%, followed by 17.8% in the second quarter.

The earnings path carries the same message. Q2 EPS of $1.78 exceeded Q1’s $1.41 but trailed the prior-year quarter’s $1.98. Trailing EPS is $5.47, only slightly above FY2025 EPS of $5.43. The reported quarter therefore supports stability and sequential recovery more readily than a fresh growth inflection.

Capital remains central to the thesis. The latest point values show $40.606B of equity, $9.191B of debt and $1.565B of cash. Those figures provide context for a moderate rather than high risk assessment, but they do not by themselves establish excess capital available for distribution. The supplied filing data also do not quantify quarterly repurchases, dividends, regulatory capital or segment-level underwriting performance. Recent headlines have emphasized buybacks, but no headline was used as evidence because the underlying figures were not included in the supplied filing extract.

There is no prior SageNoodle valuation to carry forward, so this article establishes an initial fair-value range rather than changing an earlier target. The method uses trailing EPS because conventional enterprise-value-to-EBITDA, gross margin, free-cash-flow yield and ROIC are not meaningful comparative measures for this insurer. The supplied price of $74.85 and trailing EPS of $5.47 imply a current P/E of 13.7 times.

The base case applies a 14.0 times multiple to trailing EPS of $5.47, producing fair value of $76.58 per share. That multiple is an explicit assumption rather than a management forecast. It sits close to the current market multiple and reflects the balance between improving sequential profitability and weaker year-over-year EPS. At the current price, the indicated upside is only 2.3%, which meets SageNoodle’s Fairly Valued definition rather than the 15% threshold required for Undervalued.

The bear case assumes EPS falls to $4.75 and the valuation contracts to 12.7 times, resulting in $60.33 per share. That outcome would be consistent with renewed margin pressure or earnings volatility that makes the current run rate difficult to sustain. The bull case assumes EPS reaches $6.25 and receives a 14.9 times multiple, producing $93.13 per share. It requires both better earnings and modest multiple expansion, so it cannot be justified by Q2 alone.

The probabilities are 25% for the bear case, 50% for the base case and 25% for the bull case. The base-case value is also the snapshot fair value, as required. The quarter does not warrant a premium assumption: revenue was flat, EPS fell year over year and the margin rebound was sequential rather than structural. A higher target would require evidence that stronger profitability can persist across several reporting periods.

The base case would be too conservative if Q2’s sequential improvement marks the beginning of sustained earnings growth. EPS above the $6.25 bull-case assumption, accompanied by durable pre-tax margins and sound capital management, could justify value above $93.13. The supplied data do not disclose forward guidance, however, so that outcome remains a scenario rather than a forecast.

The valuation would be too high if the year-over-year margin decline proves more informative than the sequential recovery. A return toward the 10.1% pre-tax margin reported in Q4 FY2025, or another material reduction in EPS, would undermine the use of a 14.0 times multiple. Insurance earnings can also be affected by claims, reserve development and investment results, although the supplied materials do not quantify those drivers for this quarter.

Capital allocation is another source of uncertainty. A lower share count can support per-share earnings, while poor deployment or unexpected capital needs can do the opposite. The latest share count is 533.6M, but no comparable quarterly count or repurchase detail was supplied. The thesis therefore should not credit unreported buybacks despite recent news headlines discussing them.

Finally, consolidated figures can conceal divergent segment economics. The supplied data contain no segment underwriting ratios, geographic mix, customer concentration or regulatory-capital measures. Until those disclosures are assessed, the principal test is straightforward: AIG must convert its sequential margin rebound into sustained EPS growth without weakening its balance sheet. Q2 moved in that direction from Q1, but it did not clear the year-over-year bar.